Skip to main content
Signal8

Ondrey Aaron

SEC insider (Form 3/4/5 filer). CIK 0001991078. Chief Financial Officer at ROCKET PHARMACEUTICALS, INC. (RCKT). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 3, 2025. Located in CRANBURY, NJ.

Companies Ondrey Aaron has filed insider reports for

  • ROCKET PHARMACEUTICALS, INC. (RCKT): Officer, Chief Financial Officer
Ondrey Aaron profile photo

Ondrey Aaron

CIK: 0001991078

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROCKET PHARMACEUTICALS, INC. logo
RCKT

ROCKET PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Jul 3, 2025
    Sale
    Direct
    1.5K shares at avg. $2.88$4K
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Apr 4, 2025
    Sale
    Direct
    7.5K shares at avg. $5.29$40K
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Feb 11, 2025
    Award
    Direct
    90.4K shares-

1-3 of 3